RT
VSTM icon

Robert Torray’s Verastem VSTM Stock Holding History

Robert Torray’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
477,455
+178,497
+60% +$864K 0.25% 60
2026
Q1 		$1.58M Buy
298,958
+82,571
+38% +$509K 0.23% 63
2025
Q4 		$1.67M Buy
+216,387
New +$1.93M 0.24% 68

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Robert Torray's VSTM Position: Q2 2026 in Review

Robert Torray increased its Verastem (VSTM) stake by 60% in Q2 2026, buying an estimated $864K and bringing the position to 477,455 shares worth $1.82M. The position accounts for 0.25% of the portfolio, ranked #60.

Robert Torray first reported a position in VSTM in Q4 2025 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Robert Torray held 477,455 shares of Verastem worth $1.82M as of Q2 2026.
  • Robert Torray bought 178,497 Verastem shares in Q2 2026, an estimated $864K.
  • Verastem made up 0.25% of Robert Torray's portfolio in Q2 2026, its #60 holding.
  • Robert Torray first reported a position in Verastem in Q4 2025 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Torray Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.